Advisors Asset Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $464K | Buy |
997
+113
| +13% | +$47.5K | 0.01% | 998 |
|
|
2026
Q1 | $334K | Buy |
884
+98
| +12% | +$42K | 0.01% | 1050 |
|
|
2025
Q4 | $336K | Sell |
786
-523
| -40% | -$228K | 0.01% | 1037 |
|
|
2025
Q3 | $586K | Buy |
1,309
+147
| +13% | +$66.6K | 0.01% | 937 |
|
|
2025
Q2 | $566K | Sell |
1,162
-782
| -40% | -$446K | 0.01% | 922 |
|
|
2025
Q1 | $1.2M | Sell |
1,944
-182
| -9% | -$103K | 0.02% | 704 |
|
|
2024
Q4 | $1.13M | Sell |
2,126
-1,202
| -36% | -$678K | 0.02% | 716 |
|
|
2024
Q3 | $2M | Sell |
3,328
-166
| -5% | -$94.1K | 0.04% | 554 |
|
|
2024
Q2 | $1.9M | Sell |
3,494
-1,155
| -25% | -$662K | 0.04% | 555 |
|
|
2024
Q1 | $2.98M | Buy |
4,649
+510
| +12% | +$310K | 0.06% | 430 |
|
|
2023
Q4 | $2.42M | Sell |
4,139
-1,138
| -22% | -$637K | 0.05% | 467 |
|
|
2023
Q3 | $2.74M | Buy |
5,277
+101
| +2% | +$52.5K | 0.06% | 400 |
|
|
2023
Q2 | $2.8M | Sell |
5,176
-429
| -8% | -$235K | 0.06% | 406 |
|
|
2023
Q1 | $3.01M | Buy |
5,605
+66
| +1% | +$33.7K | 0.06% | 384 |
|
|
2022
Q4 | $2.83M | Sell |
5,539
-678
| -11% | -$330K | 0.06% | 393 |
|
|
2022
Q3 | $2.71M | Buy |
6,217
+3
| +0% | +$1.44K | 0.05% | 408 |
|
|
2022
Q2 | $2.92M | Sell |
6,214
-451
| -7% | -$220K | 0.05% | 385 |
|
|
2022
Q1 | $3.38M | Sell |
6,665
-21
| -0.3% | -$10.1K | 0.05% | 405 |
|
|
2021
Q4 | $3.54M | Sell |
6,686
-60
| -0.9% | -$28.8K | 0.05% | 409 |
|
|
2021
Q3 | $3.14M | Sell |
6,746
-86
| -1% | -$40.5K | 0.05% | 431 |
|
|
2021
Q2 | $3.24M | Buy |
6,832
+96
| +1% | +$46.1K | 0.05% | 421 |
|
|
2021
Q1 | $3.1M | Sell |
6,736
-2,135
| -24% | -$1.05M | 0.05% | 419 |
|
|
2020
Q4 | $4.72M | Buy |
8,871
+691
| +8% | +$340K | 0.07% | 263 |
|
|
2020
Q3 | $3.93M | Buy |
8,180
+874
| +12% | +$429K | 0.07% | 258 |
|
|
2020
Q2 | $3.3M | Sell |
7,306
-144
| -2% | -$64.3K | 0.06% | 306 |
|
|
2020
Q1 | $3.23M | Buy |
7,450
+79
| +1% | +$35.3K | 0.07% | 267 |
|
|
2019
Q4 | $3.24M | Buy |
7,371
+2,085
| +39% | +$877K | 0.06% | 377 |
|
|
2019
Q3 | $2.21M | Buy |
5,286
+543
| +11% | +$222K | 0.04% | 497 |
|
|
2019
Q2 | $1.71M | Buy |
4,743
+455
| +11% | +$152K | 0.03% | 604 |
|
|
2019
Q1 | $1.37M | Buy |
4,288
+568
| +15% | +$174K | 0.03% | 678 |
|
|
2018
Q4 | $1.05M | Sell |
3,720
-81
| -2% | -$24.4K | 0.02% | 743 |
|
|
2018
Q3 | $1.22M | Buy |
3,801
+749
| +25% | +$239K | 0.02% | 776 |
|
|
2018
Q2 | $982K | Sell |
3,052
-1,592
| -34% | -$498K | 0.02% | 849 |
|
|
2018
Q1 | $1.21M | Buy |
4,644
+254
| +6% | +$67.3K | 0.02% | 771 |
|
|
2017
Q4 | $1.07M | Sell |
4,390
-484
| -10% | -$110K | 0.02% | 825 |
|
|
2017
Q3 | $985K | Sell |
4,874
-4,939
| -50% | -$971K | 0.02% | 870 |
|
|
2017
Q2 | $2.01M | Buy |
9,813
+532
| +6% | +$106K | 0.03% | 624 |
|
|
2017
Q1 | $1.7M | Buy |
9,281
+2,057
| +28% | +$359K | 0.03% | 688 |
|
|
2016
Q4 | $1.16M | Sell |
7,224
-4,594
| -39% | -$675K | 0.02% | 831 |
|
|
2016
Q3 | $1.67M | Sell |
11,818
-7,497
| -39% | -$1.04M | 0.03% | 686 |
|
|
2016
Q2 | $2.63M | Sell |
19,315
-5,953
| -24% | -$790K | 0.04% | 566 |
|
|
2016
Q1 | $3.42M | Sell |
25,268
-826
| -3% | -$112K | 0.06% | 474 |
|
|
2015
Q4 | $3.91M | Buy |
26,094
+1,470
| +6% | +$217K | 0.06% | 451 |
|
|
2015
Q3 | $3.29M | Buy |
24,624
+5,415
| +28% | +$758K | 0.05% | 482 |
|
|
2015
Q2 | $2.52M | Buy |
+19,209
| New | +$2.38M | 0.03% | 593 |
|
Other funds holding CHE
EIP
Advisors Asset Management's CHE Position: Q2 2026 in Review
Advisors Asset Management increased its Chemed (CHE) stake by 13% in Q2 2026, buying an estimated $47.5K and bringing the position to 997 shares worth $464K. The position accounts for 0.01% of the portfolio, ranked #998.
Advisors Asset Management first reported a position in CHE in Q2 2015 and has held it in 45 quarters since. The position peaked at $4.72M in Q4 2020. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Advisors Asset Management held 997 shares of Chemed worth $464K as of Q2 2026.
- Advisors Asset Management bought 113 Chemed shares in Q2 2026, an estimated $47.5K.
- Chemed made up 0.01% of Advisors Asset Management's portfolio in Q2 2026, its #998 holding.
- Advisors Asset Management first reported a position in Chemed in Q2 2015 and has held it in 45 quarters since.
- Advisors Asset Management's Chemed position peaked at $4.72M in Q4 2020.
- 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.